biodefense, biopharmaceutical, biomanufacturing, biodevelopment, protein-production, expression optimization, FACS, antibody development, therapeutic-antibodies, pBFdhfr.2, smallpox, MUC7, mucin, lassa fever, DHFR, cGMP-manufacturing, clinical-trials, Darryl Sampey, Alex Matschiner, Luis Branco, USAMRIID, MTECH, MdBio, Robert F. Garry, Tulane University, University at Buffalo, Patrick Huddie, Robert Gillette, William G. Hearl, Fazal Khan biodefense, biopharmaceutical, biomanufacturing, biodevelopment, protein-production, expression optimization, FACS, antibody development, therapeutic-antibodies, pBFdhfr.2, smallpox, MUC7, mucin, lassa fever, DHFR, cGMP-manufacturing, clinical-trials, Darryl Sampey, Alex Matschiner, Luis Branco, USAMRIID, MTECH, MdBio, Robert F. Garry, Tulane University, University at Buffalo, Patrick Huddie, Robert Gillette, William G. Hearl, Fazal Khan biodefense, biopharmaceutical, biomanufacturing, biodevelopment, protein-production, expression optimization, FACS, antibody development, therapeutic-antibodies, pBFdhfr.2, smallpox, MUC7, mucin, lassa fever, DHFR, cGMP-manufacturing, clinical-trials, Darryl Sampey, Alex Matschiner, Luis Branco, USAMRIID, MTECH, MdBio, Robert F. Garry, Tulane University, University at Buffalo, Patrick Huddie, Robert Gillette, William G. Hearl, Fazal Khan biodefense, biopharmaceutical, biomanufacturing, biodevelopment, protein-production, expression optimization, FACS, antibody development, therapeutic-antibodies, pBFdhfr.2, smallpox, MUC7, mucin, lassa fever, DHFR, cGMP-manufacturing, clinical-trials, Darryl Sampey, Alex Matschiner, Luis Branco, USAMRIID, MTECH, MdBio, Robert F. Garry, Tulane University, University at Buffalo, Patrick Huddie, Robert Gillette, William G. Hearl, Fazal Khan biodefense, biopharmaceutical, biomanufacturing, biodevelopment, protein-production, expression optimization, FACS, antibody development, therapeutic-antibodies, pBFdhfr.2, smallpox, MUC7, mucin, lassa fever, DHFR, cGMP-manufacturing, clinical-trials, Darryl Sampey, Alex Matschiner, Luis Branco, USAMRIID, MTECH, MdBio, Robert F. Garry, Tulane University, University at Buffalo, Patrick Huddie, Robert Gillette, William G. Hearl, Fazal Khan
BioFactura, Inc.
9700 Great Seneca HwyTel:  301-315-8002
Rockville, MD 20850Fax: 240-597-6340
01 JAN 08
BioFactura Announces $1 Million Congressional Appropriation to Support Its Smallpox Biodefense Therapeutic Program
30 OCT 07
BioFactura Announces Positive Results in Development of New Rapid Diagnostic Tests for Viral Hemorrhagic Fever Infections and Bioterrorism Threats
23 JAN 07
MdBio Foundation Awards BioFactura Accelerator Investment